Literature DB >> 15066903

Correlation between brain bradykinin receptor binding sites and cardiovascular function in young and adult spontaneously hypertensive rats.

Frank Cloutier1, Brice Ongali, Maria M Campos, Gaétan Thibault, Witold Neugebauer, Réjean Couture.   

Abstract

Intracerebroventricular (i.c.v.) effects of bradykinin (BK) B(1) and B(2) receptor agonists and antagonists were assessed on mean arterial blood pressure (MAP) and heart rate (HR) in awake unrestrained spontaneously hypertensive rats (SHR, aged of 8 and 16 weeks) and age-matched Wistar Kyoto rats (WKY). Quantitative in vitro autoradiographic studies were also performed on the brain of both strains with specific radioligands for B(2) receptors [(125)I]HPP-Hoe 140 and B(1) receptors [(125)I]HPP-des-Arg(10) and Hoe140. MAP increased linearly with doses of BK (81-8100 pmol) and the amplitudes were significantly greater in SHR, particularly at 16 weeks. While BK evoked a negative linear trend on HR (bradycardia) in WKY, a positive one (tachycardia) was observed in adult SHR. In both strains, BK-induced pressor response was blocked by equimolar doses of B(2) receptor antagonist, D-Arg-[Hyp(3), Thi(5), D-Tic(7), Oic(8)]-BK (Hoe 140), but not by B(1) receptor antagonist, AcLys[D-betaNal(7), Ile(8)]des-Arg(9)-BK (R-715). B(1) receptor agonists (Sar-[D-Phe(8)]-des-Arg(9)-BK, des-Arg(9)-BK, des-Arg(10)-Kallidin) and antagonist (R-715 alone or with Hoe 140) had no or marginal effect on MAP and HR at doses up to 8100 pmol in SHR and WKY. Higher densities of specific [(125)I]HPP-Hoe 140 labelling were found in discrete brain areas of SHR, especially in regions associated with cardiovascular function. Low levels of [(125)I]HPP-[des-Arg(10)]-Hoe140 binding sites were seen in WKY and SHR, yet densities were significantly greater in midbrain and cortical regions of SHR aged of 16 weeks. Contrary to SHR, ageing caused a downregulation of B(2) and B(1) receptor binding sites in specific brain nuclei in WKY. It is concluded that the hypersensitivity of the pressor response to i.c.v. BK in SHR occurs during both the early and established phases of hypertension in parallel with the enhancement of B(2) receptor binding sites in various cardiovascular brain centres. In contrast, brain B(1) receptors do not seem to participate in the central pressor effects of kinins nor in the maintenance of hypertension in SHR.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15066903      PMCID: PMC1574947          DOI: 10.1038/sj.bjp.0705759

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  39 in total

1.  Centrally bradykinin B2-receptor-induced hypertensive and positive chronotropic effects are mediated via activation of the sympathetic nervous system.

Authors:  F Qadri; L Bäurle; W Häuser; W Rascher; P Dominiak
Journal:  J Hypertens       Date:  1999-09       Impact factor: 4.844

2.  Distribution of bradykinin B2 receptors in sheep brain and spinal cord visualized by in vitro autoradiography.

Authors:  C Murone; G Paxinos; M J McKinley; B J Oldfield; W Muller-Esterl; F A Mendelsohn; S Y Chai
Journal:  J Comp Neurol       Date:  1997-05-05       Impact factor: 3.215

Review 3.  The B1 receptors for kinins.

Authors:  F Marceau; J F Hess; D R Bachvarov
Journal:  Pharmacol Rev       Date:  1998-09       Impact factor: 25.468

4.  The central pressor effect of bradykinin in normotensive and hypertensive rats.

Authors:  C J Lindsey; K Fujita; T O Martins
Journal:  Hypertension       Date:  1988-02       Impact factor: 10.190

Review 5.  Brain injury: prolonged induction of transcription factors.

Authors:  K R Pennypacker; C A Kassed; S Eidizadeh; J P O'Callaghan
Journal:  Acta Neurobiol Exp (Wars)       Date:  2000       Impact factor: 1.579

6.  Chronic effects of angiotensin-converting enzyme inhibition on kinin receptor binding sites in the rat spinal cord.

Authors:  Brice Ongali; Hudson de Sousa Buck; Frank Cloutier; Francine Legault; Domenico Regoli; Chantal Lambert; Gaétan Thibault; Réjean Couture
Journal:  Am J Physiol Heart Circ Physiol       Date:  2003-02-13       Impact factor: 4.733

7.  The bradykinin B1 receptor and the central regulation of blood pressure in spontaneously hypertensive rats.

Authors:  C Emanueli; J Chao; D Regoli; L Chao; A Ni; P Madeddu
Journal:  Br J Pharmacol       Date:  1999-04       Impact factor: 8.739

8.  Brain kallikrein-kinin system abnormalities in spontaneously hypertensive rats.

Authors:  I M Khan; D H Miller; J Strickland; H S Margolius; P J Privitera
Journal:  Hypertension       Date:  1995-04       Impact factor: 10.190

9.  Cardiovascular effects of brain kinin receptor blockade in spontaneously hypertensive rats.

Authors:  P Madeddu; N Glorioso; M V Varoni; M P Demontis; M C Fattaccio; V Anania
Journal:  Hypertension       Date:  1994-01       Impact factor: 10.190

10.  Central bradykininergic system in normotensive and hypertensive rats.

Authors:  A L Alvarez; A Delorenzi; D Santajuliana; S Finkielman; V E Nahmod; C J Pirola
Journal:  Clin Sci (Lond)       Date:  1992-05       Impact factor: 6.124

View more
  12 in total

Review 1.  Astrocytes and the Renin Angiotensin System: Relevance in Disease Pathogenesis.

Authors:  Ann Tenneil O'Connor; Michelle A Clark
Journal:  Neurochem Res       Date:  2018-06-01       Impact factor: 3.996

2.  Modulation of cardiac vagal tone by bradykinin acting on nucleus ambiguus.

Authors:  Eugen Brailoiu; Matthew McGuire; Shadaria A Shuler; Elena Deliu; Jeffrey L Barr; Mary E Abood; G Cristina Brailoiu
Journal:  Neuroscience       Date:  2017-09-23       Impact factor: 3.590

3.  Acute angiotensin-converting enzyme inhibition evokes bradykinin-induced sympathetic activation in diabetic rats.

Authors:  Robert A Augustyniak; Maria Maliszewska-Scislo; Haiping Chen; John Fallucca; Noreen F Rossi
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2007-09-26       Impact factor: 3.619

4.  Upregulation of tachykinin NK-1 and NK-3 receptor binding sites in the spinal cord of spontaneously hypertensive rat: impact on the autonomic control of blood pressure.

Authors:  Frank Cloutier; Brice Ongali; Kathleen Deschamps; Jonathan Brouillette; Witold Neugebauer; Réjean Couture
Journal:  Br J Pharmacol       Date:  2006-05       Impact factor: 8.739

5.  Kinin B1 Receptor Promotes Neurogenic Hypertension Through Activation of Centrally Mediated Mechanisms.

Authors:  Srinivas Sriramula; Eric Lazartigues
Journal:  Hypertension       Date:  2017-10-16       Impact factor: 10.190

6.  Excess of Aminopeptidase A in the Brain Elevates Blood Pressure via the Angiotensin II Type 1 and Bradykinin B2 Receptors without Dipsogenic Effect.

Authors:  Takuto Nakamura; Masanobu Yamazato; Akio Ishida; Yusuke Ohya
Journal:  Int J Hypertens       Date:  2017-03-22       Impact factor: 2.420

7.  Targeting intracellular B2 receptors using novel cell-penetrating antagonists to arrest growth and induce apoptosis in human triple-negative breast cancer.

Authors:  Céléna Dubuc; Martin Savard; Veronica Bovenzi; Andrée Lessard; Audrey Fortier; Jérôme Côté; Witold Neugebauer; Flavio Rizzolio; Sameh Geha; Antonio Giordano; Sylvain Chemtob; Fernand Gobeil
Journal:  Oncotarget       Date:  2018-01-05

8.  Hypothalamic kinin B1 receptor mediates orexin system hyperactivity in neurogenic hypertension.

Authors:  Rohan Umesh Parekh; Acacia White; Korin E Leffler; Vinicia C Biancardi; Jeffrey B Eells; Abdel A Abdel-Rahman; Srinivas Sriramula
Journal:  Sci Rep       Date:  2021-10-26       Impact factor: 4.996

9.  Kinin B1 Receptor Blockade Prevents Angiotensin II-induced Neuroinflammation and Oxidative Stress in Primary Hypothalamic Neurons.

Authors:  Rohan Umesh Parekh; Jacques Robidoux; Srinivas Sriramula
Journal:  Cell Mol Neurobiol       Date:  2019-12-21       Impact factor: 5.046

10.  Analysis of Heart-Rate Variability during Angioedema Attacks in Patients with Hereditary C1-Inhibitor Deficiency.

Authors:  Francesca Perego; Beatrice De Maria; Maria Bova; Angelica Petraroli; Azzurra Marcelli Cesoni; Valeria De Grazia; Lorenza Chiara Zingale; Alberto Porta; Giuseppe Spadaro; Laura Adelaide Dalla Vecchia
Journal:  Int J Environ Res Public Health       Date:  2021-03-12       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.